Latest Sydney News

Dicker Data has outperformed its FY25 guidance, delivering a 14.9% jump in gross revenue to $3.876 billion, fuelled by AI deals and infrastructure refreshes. The company’s FY26 outlook anticipates continued momentum in AI and data centre projects despite pricing pressures.

Cryosite Limited delivered a robust 22% revenue increase and 28% EBITDA growth for the ten months to April 2026, powered by expanding clinical trial activity and infrastructure upgrades.

Eagers Automotive delivered record $13 billion revenue and underlying EBITDAI of $620.9 million in 2025, boosted by strategic investments in CanadaOne Auto and Mitsubishi Corporation. The company’s 2026 outlook is positive, supported by strong order books and easing supply constraints.

ASX Limited projects a significant 18-21% rise in expenses for FY27 driven by technology modernisation and regulatory response, while increasing capital expenditure guidance to up to $200 million.

SciDev Ltd has announced an immediate CEO transition with CFO Todd Scott stepping up to lead, as outgoing CEO Seán Halpin moves to an advisory role. The company also names John Gardiner as interim CFO while seeking a permanent replacement.

Pure Foods Tasmania appoints Robert Knight as CEO and Managing Director, aligning leadership with shareholder interests amid ongoing growth and turnaround efforts.

Charter Hall Group upgrades its FY26 operating earnings guidance by 3%, buoyed by record institutional capital inflows and expanding funds under management reaching $74.7 billion.

Electro Optic Systems (ASX:EOS) invites eligible shareholders to participate in a capped A$25 million Share Purchase Plan at the same price as its recent A$150 million institutional placement, supporting its MARSS acquisition and growth strategy.

Argo Global Listed Infrastructure Limited (ASX: ALI) has opened a Share Purchase Plan allowing eligible shareholders to buy up to $30,000 of new shares at a discount, aiming to boost fund size and cost efficiency.

OncoSil Medical has clinched TGA approval for its OncoSil™ device, the first Class III medical device targeting pancreatic tumours in Australia, paving the way for local commercialisation and enhanced patient access.

Plenti Group Limited (ASX:PLT) has smashed its $3 billion loan portfolio target two months ahead of schedule, delivering a 117% surge in cash profit before tax to $30.8 million for FY26. The fintech lender’s growth was fuelled by record loan originations, robust credit performance, and strategic technology investments.

BCAL Diagnostics has embedded referral forms for its early cancer detection tests into clinical software used by 97% of Australian GPs, launched a telehealth platform, and opened a Sydney clinic, gearing up for a multi-cancer test launch in June 2026.